Free Trial

Quoin Pharmaceuticals (QNRX) Short Interest Ratio & Short Volume

Quoin Pharmaceuticals logo
$8.37 -0.10 (-1.18%)
Closing price 03:59 PM Eastern
Extended Trading
$8.28 -0.08 (-1.02%)
As of 05:36 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Quoin Pharmaceuticals Short Interest Data

Quoin Pharmaceuticals (QNRX) has a short interest of 19,200 shares. This marks a 53.60% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.1, indicating that it would take 0.1 days of the average trading volume of 134,802 shares to cover all short positions.

Current Short Interest
19,200 shares
Previous Short Interest
12,500 shares
Change Vs. Previous Month
+53.60%
Dollar Volume Sold Short
$129,984.00
Short Interest Ratio
0.1 Days to Cover
Last Record Date
April 30, 2025
Outstanding Shares
588,000 shares
Percentage of Shares Shorted
3.27%
Today's Trading Volume
27,699 shares
Average Trading Volume
134,802 shares
Today's Volume Vs. Average
21%
Short Selling Quoin Pharmaceuticals?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Quoin Pharmaceuticals and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

QNRX Short Interest Over Time

QNRX Days to Cover Over Time

QNRX Percentage of Float Shorted Over Time

Quoin Pharmaceuticals Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
4/30/202519,200 shares $129,984.00 +53.6%N/A0.1 $6.77
4/15/202512,500 shares $73,375.00 +150.0%0.3%0 $5.87
3/31/20255,000 shares $39,182.50 -99.4%0.1%0 $7.84
3/15/2025868,800 shares $264,462.72 -67.6%17.9%0.2 $0.30
2/28/20252,680,000 shares $832,676.00 +5,936.0%55.1%0.5 $0.31
2/15/202544,400 shares $13,692.96 -15.9%0.9%0 $0.31
1/31/202552,800 shares $17,424.00 -87.1%1.1%0 $0.33
1/15/2025410,400 shares $240,042.96 -40.8%N/A0.2 $0.58
12/31/2024693,000 shares $450,935.10 +310.3%N/A0.2 $0.65
12/15/2024168,900 shares $111,811.80 +77.4%N/A0.1 $0.66
11/30/202495,200 shares $57,120.00 -65.3%N/A0 $0.60
11/15/2024274,500 shares $170,244.90 -42.6%N/A0.1 $0.62
10/31/2024478,400 shares $357,412.64 +2,391.7%N/A0.2 $0.75
10/15/202419,200 shares $9,676.80 +26.3%N/A0 $0.50
9/30/202415,200 shares $7,493.60 -92.1%N/A0 $0.49
9/15/2024193,500 shares $116,351.55 +1,473.2%N/A0.4 $0.60
8/31/202412,300 shares $7,701.03 +373.1%N/A0 $0.63
8/15/20242,600 shares $1,299.74 -80.5%N/A0.1 $0.50
7/31/202413,300 shares $7,985.32 +118.0%N/A0.3 $0.60
7/15/20246,100 shares $3,990.01 -52.7%N/A0.1 $0.65
6/30/202412,900 shares $7,482.00 +148.1%N/A0.2 $0.58
6/15/20245,200 shares $3,568.24 -56.3%N/A0.1 $0.69
5/31/202411,900 shares $9,247.49 +325.0%N/A0.1 $0.78
5/15/20242,800 shares $2,172.80 -70.5%N/A0 $0.78
4/30/20249,500 shares $6,726.00 -37.9%N/A0 $0.71
4/15/202415,300 shares $11,245.50 +31.9%N/A0 $0.74
3/31/202411,600 shares $11,020.00 -65.6%N/A0 $0.95
3/15/202433,700 shares $32,250.90 +159.2%N/A0.1 $0.96
2/29/202413,000 shares $35,815.00 +381.5%N/A0 $2.76
2/15/20242,700 shares $7,533.00 +8.0%N/A0.1 $2.79
1/31/20242,500 shares $8,925.00 +212.5%N/A0.1 $3.57
1/15/2024800 shares $3,552.00 -87.3%N/A0 $4.44
12/31/20236,300 shares $30,901.50 -78.6%N/A0.2 $4.91
12/15/202329,400 shares $127,596.00 +2,840.0%N/A0.9 $4.34
11/30/20231,000 shares $4,973.10 -85.7%N/A0.1 $4.97
11/15/20237,000 shares $29,750.00 +133.3%N/A0.4 $4.25
10/31/20233,000 shares $12,210.00 -30.2%N/A0.1 $4.07
10/15/20234,300 shares $16,985.00 +87.0%N/A0.1 $3.95
9/30/20232,300 shares $9,545.00 -30.3%N/A0 $4.15
9/15/20233,300 shares $18,183.00 -64.5%N/A0 $5.51
Think NVDA’s run was epic? You ain’t seen nothin’ yet (Ad)

Ask most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, it surged 239%. And in 2024, it soared another 171% on the year… But what if I told you there was a way to target those types of “peak Nvidia” profit opportunities in 24 hours or less?

Click to find out what Nvidia’s CEO might reveal… and how Sykes is preparing to ride the wave.
8/31/20239,300 shares $53,475.00 -30.6%N/A0.1 $5.75
8/15/202313,400 shares $71,824.00 -76.2%N/A0.1 $5.36
7/31/202356,200 shares $442,294.00 +524.4%N/A0.4 $7.87
7/15/20239,000 shares $60,480.00 -94.0%N/A0.1 $6.72
6/30/2023149,400 shares $74,746.61 +76.8%N/A0.6 $0.50
6/15/202384,500 shares $45,630.00 +0.7%N/A0.3 $0.54
5/31/202383,900 shares $35,699.45 +156.6%N/A0.3 $0.43
5/15/202332,700 shares $15,924.90 -84.1%N/A0.1 $0.49
4/30/2023205,500 shares $102,750.00 +448.0%N/A0.4 $0.50
4/15/202337,500 shares $19,031.25 -29.1%N/A0.1 $0.51
3/31/202352,900 shares $25,159.24 -62.3%N/A0.1 $0.48
3/15/2023140,400 shares $71,491.68 +61.6%N/A0.2 $0.51
2/28/202386,900 shares $49,498.24 -73.6%N/A0.1 $0.57
2/15/2023328,900 shares $509,795.00 +1,118.2%N/A0.6 $1.55
1/31/202327,000 shares $45,090.00 +52.5%N/A0.1 $1.67
1/15/202317,700 shares $29,382.00 +46.3%N/A0.1 $1.66
12/30/202212,100 shares $17,182.00 +27.4%N/A0 $1.42
12/15/20229,500 shares $14,535.00 -33.6%N/A0 $1.53
11/30/202214,300 shares $23,881.00 -74.8%N/A0 $1.67
11/15/202256,700 shares $108,297.00 -33.7%N/A0 $1.91
10/31/202285,500 shares $158,175.00 +152.2%N/A0.1 $1.85
10/15/202233,900 shares $57,969.00 -1.5%N/A0 $1.71
9/30/202234,400 shares $76,712.00 -85.6%N/A0 $2.23
9/15/2022238,800 shares $940,872.00 +423.7%N/A0.1 $3.94
8/31/202245,600 shares $149,112.00 -71.9%N/A0 $3.27
8/15/2022162,000 shares $764,640.00 +116.9%N/A0.1 $4.72
7/31/202274,700 shares $333,068.63 -92.4%N/A0.1 $4.46
7/15/2022986,500 shares $404,465.00 +19.1%N/A0.3 $0.41
6/30/2022828,300 shares $372,735.00 +162.8%N/A0.3 $0.45
6/15/2022315,200 shares $124,188.80 +923.4%N/A0.2 $0.39
5/31/202230,800 shares $19,558.00 -34.2%N/A0 $0.64
5/15/202246,800 shares $29,165.76 -83.5%N/A0.1 $0.62
4/30/2022284,200 shares $227,644.20 +120.7%N/A0.4 $0.80
4/15/2022128,800 shares $157,136.00 -14.1%N/A0.2 $1.22
3/31/2022150,000 shares $199,500.00 -33.9%N/A0.1 $1.33
3/15/2022226,900 shares $283,625.00 +94.8%N/A0.1 $1.25
2/28/2022116,500 shares $129,315.00 -45.9%N/A0.1 $1.11
2/15/2022215,300 shares $305,726.00 +192.5%N/A0.1 $1.42
1/31/202273,600 shares $102,304.00 -59.5%N/A0 $1.39
1/15/2022181,500 shares $294,030.00 -6.0%N/A0.1 $1.62
12/31/2021193,100 shares $351,442.00 No ChangeN/A0.1 $1.82

QNRX Short Interest - Frequently Asked Questions

What is Quoin Pharmaceuticals' current short interest?

Short interest is the volume of Quoin Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of April 30th, investors have sold 19,200 shares of QNRX short. Learn More on Quoin Pharmaceuticals' current short interest.

Is Quoin Pharmaceuticals' short interest increasing or decreasing?

Quoin Pharmaceuticals saw a increase in short interest in April. As of April 30th, there was short interest totaling 19,200 shares, an increase of 53.6% from the previous total of 12,500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Quoin Pharmaceuticals' short interest compare to its competitors?

Here is how the short interest of companies in the industry of "medical equipment" compare to Quoin Pharmaceuticals: NEXGEL, Inc. (1.18%), IRIDEX Co. (2.18%), Nexalin Technology, Inc. (1.11%), Beyond Air, Inc. (3.11%), ReWalk Robotics Ltd. (4.24%), Vivos Therapeutics, Inc. (5.65%), SeaStar Medical Holding Co. (2.95%), PAVmed Inc. (2.08%), DIH Holding US, Inc. (1.02%), STRATA Skin Sciences, Inc. (0.07%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Spotify Technology S.A. ($4.67 billion), Charter Communications, Inc. ($4.58 billion), Capital One Financial Co. ($4.47 billion), The Kroger Co. ($2.56 billion), Reddit, Inc. ($2.23 billion), Rivian Automotive, Inc. ($2.16 billion), Live Nation Entertainment, Inc. ($1.90 billion), SoFi Technologies, Inc. ($1.85 billion), Zscaler, Inc. ($1.75 billion), and Omnicom Group Inc. ($1.75 billion). View all of the most shorted stocks.

What does it mean to sell short Quoin Pharmaceuticals stock?

Short selling QNRX is an investing strategy that aims to generate trading profit from Quoin Pharmaceuticals as its price is falling. QNRX shares are trading down $0.10 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Quoin Pharmaceuticals?

A short squeeze for Quoin Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of QNRX, which in turn drives the price of the stock up even further.

How often is Quoin Pharmaceuticals' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including QNRX, twice per month. The most recent reporting period available is April, 30 2025.




This page (NASDAQ:QNRX) was last updated on 5/21/2025 by MarketBeat.com Staff
From Our Partners